Explore what’s happening here
Sumitomo Dainippon Pharma Oncology, Inc. is advancing innovative science and transforming new discoveries into meaningful therapeutic options for patients with cancer. To learn more about our most recent discoveries, commercial efforts, and cancer care projects, see our press releases and other news below.
To contact our media relations staff, click here.
Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical
Sumitomo Dainippon Pharma Oncology Advances Meaningful Therapies for Cancer Patients through Innovative Drug Discovery, Research and Development.